Pheochromocytoma: Update on diagnosis and therapy;Phäochromozytom: Diagnostik und Therapie

Deutsche Medizinische Wochenschrift

Volumn 139, Issue 10, 2014, Pages 486-489

  Gruber, M ^a   Darr R ^a   Eisenhofer, G ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

neuroendocrine tumors; paraganglioma; pheochromocytoma

Indexed keywords

CANCER THERAPY; HUMAN; PHEOCHROMOCYTOMA; REVIEW;

ADRENAL GLAND NEOPLASMS; CATECHOLAMINES; DIAGNOSIS, DIFFERENTIAL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; PHEOCHROMOCYTOMA; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 84896861437     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0033-1360082     Document Type: Review

References (20)

1. Anderson G. H. Jr, Blakeman N., Streeten D. H. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens: 1994; 12 609 615
2. Cawood T. J., Hunt P. J., O'Shea D. et al. Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur J Endocrinol: 2009; 161 513 527
3. Därr R., Lenders J. W., Hofbauer L. C. et al. Pheochromocytoma - update on disease management. Ther Adv Endocrinol Metab: 2012; 3 11 26
4. Därr R., Lenders J. W., Stange K. et al. Diagnosis of pheochromocytoma and paraganglioma: the clonidine suppression test in patients with borderline elevations of plasma free normetanephrine. Dtsch Med Wochenschr: 2013; 138 76 81
5. Därr R., Pamporaki C., Peitzsch M. et al. Biochemical diagnosis of phaeochromocytoma using plasma free normetanephrine, metanephrine and methoxytyramine: Importance of supine sampling under fasting conditions. Clin Endocrinol: 2013; Sep 18. doi: 10.1111/cen.12327 [Epub ahead of print]
6. Eisenhofer G., Bornstein S. R. Surgery: Risks of hemodynamic instability in pheochromocytoma. Nat Rev Endocrinol: 2010; 6 06 301 2
7. Eisenhofer G., Goldstein D. S., Sullivan P. et al. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab: 2005; 90 04 2068 2075
8. Eisenhofer G., Lenders J. W., Siegert G. et al. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer: 2012; 48 1739 1749
9. Eisenhofer G., Lenders J. W., Timmers H. et al. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem: 2011; 57 411 420
10. Fishbein L., Orlowski R., Cohen D. Pheochromocytoma/Paraganglioma: Review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma. J Clin Hypertens (Greenwich): 2013; 15 428 434
11. Groeben H. Präoperative a-Rezeptoren-Blockade beim Phäochromozytom? - Kontra. Chirurg: 2012; 83 551 554
12. Hariskov S., Schumann R. Intraoperative management of patients with incidental catecholamine producing tumors: A literature review and analysis. J Anaesthesiol Clin Pharmacol: 2013; 29 41 46
13. Karasek D., Shah U., Frysak Z. et al. An update on the genetics of pheochromocytoma. J Hum Hypertens: 2013; 27 141 147
14. Mannelli M., Lenders J. W., Pacak K. et al. Subclinical phaeochromocytoma. Best Pract Res Clin Endocrinol Metab: 2012; 26 507 15
15. Pacak K., Linehan W. M., Eisenhofer G. et al. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med: 2001; 134 315 29
16. Peitzsch M., Prejbisz A., Kroiss M. et al. Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma. Ann Clin Biochem: 2013; 50 (Pt 2) 147 155
17. Rufini V., Treglia G., Castaldi P. et al. Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review. Q J Nucl Med Mol Imaging: 2013; 57 122 133
18. Shen J., Yu R. Perioperative management of pheochromocytoma: the heart of the issue. Minerva Endocrinol: 2013; 38 77 93
19. Vicha A., Musil Z., Pacak K. Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options. Curr Opin Endocrinol Diabetes Obes: 2013; 20 186 191
20. Taieb D., Yang C., Delenne B. et al. First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia- paraganglioma syndrome. J Clin Endocrinol Metab: 2013; 98 E908 E913